Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUL 13 ... and sulfonylureas. As a result, there is also no proof of additional benefit. Although repaglinide has been approved for 10 years and nateglinide for 8 years in Germany, there have been ...
Subject: Institute for Quality and Efficiency in Health Care
2009 MAY 4 ... activity, reduce sensitivity to inhibitory ATP and channel inhibitors, glibenclamide and repaglinide, and cause neonatal diabetes. We compared Kir6.x/SUR1 channels carrying the V59G ...
2009 APR 13 ... Investigators publish new data in the report 'The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range.' In this recent study, researchers ...
2009 JUL 6 ... prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide,' are discussed in a new report. "Hypoglycaemia is an acute complication ...
2009 FEB 16 ... response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control' have been presented. "Our aim was to study, at the ...
2009 FEB 16 ... and Sciele Pharma, Inc., a Shionogi Company, announced the availability of PrandiMet® (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the ...
2009 SEP 21 ... Levels. The study investigated the effects of 2 oral antidiabetics, pioglitazone and repaglinide, on the mentioned parameters. It is concluded that pioglilazone exerts Protective effect ...
2009 OCT 5 ... report, researchers in the United States conducted a study "To assess the use of a new repaglinide/metformin fixed-dose combination (FDC) tablet for the treatment of type 2 diabetes. In ...
2009 NOV 1 ... in the United States conducted a study "To assess the efficacy and safety of a new repaglinide/metformin fixed-dose combination (FDC) tablet administered either twice a day (BID) or ...
2009 JUN 8 ... insulin alone. In this study, the effects of insulin glargine (IG) in combination with repaglinide or acarbose on glycemic parameters were investigated," scientists writing in the ...
2009 NOV 1 ... a short-acting type oral blood glucose regulator, not only nateglinide but meglitinides (repaglinide, mitiglinide, etc.) was suggested to enable control of both PBG and FBG for moderate and ...
2009 JUN 8 ... who were newly diagnosed with T2DM and received a 48 week treatment of a single drug, repaglinide, metformin or rosiglitazone. Fasting overnight and 2 h postprandial blood serum of ...
2009 APR 13 ... in Pavia, Italy conducted a study "To compare the metabolic effects of acarbose and repaglinide in type 2 diabetic patients who are being treated with a sulphonylurea-metformin ...
2008 OCT 20 ... the association of KCNJ11 E23K and ABCC8 exon16-3T/C with the therapeutic effect of repaglinide in patients with type 2 diabetes. A total of 100 Chinese patients with newly diagnosed ...
2008 OCT 13 ... by 150% at 25 mc M compared with 4-hydroxyisoleucine and insulin secretagogue drug repaglinide," wrote D. Sergent and colleagues.
The researchers concluded: "In view ...
2008 NOV 10 ... doses of 1,200 mg gemfibrozil, 40 mg atorvastatin, or placebo, followed by 0.25 mg of repaglinide on day 3. The mean increase in the repaglinide area ...
2008 SEP 30 ... to recent research published in the journal Clinical Pharmacology & Therapeutics, "Repaglinide is metabolized by cytochrome P450 (CYP) 2C8 and 3A4. gemfibrozil has the effect of ...
